| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24c714f929a56f57a3fe0bc0ec04b800 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2020-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4d88ead7b2aa01f5305be9f8d08265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bb4ca57f269c0c6a247b2f95a3d2352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59475eb0ecbce429fabf834b6fdf266c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb1e085c802478b2caade0a4d2259f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5845d029e19972928ca9a829872b36f6 |
| publicationDate |
2020-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020236679-A1 |
| titleOfInvention |
Methods and compositions for determining the biodistribution of activatable anti-cd166 antibody conjugates |
| abstract |
The present invention provides methods, compounds, and compositions useful for determining the in vivo distribution of a radionuclide after administering a radiolabeled activatable anti-CD166 antibody-bioactive agent conjugate to a subject by positron emission tomography imaging. The present invention also provides methods for identifying subjects suitable for treatment with the corresponding non-radiolabeled activatable anti-CD166-bioactive agent conjugates. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023192606-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023183888-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023183923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023192973-A1 |
| priorityDate |
2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |